School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
Search for other papers by Marra Jai Aghajani in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
South West Sydney Clinical School, UNSW Sydney, Sydney, Australia
Search for other papers by Tara Laurine Roberts in
Google Scholar
PubMed
Saint Vincent’s Clinical School, UNSW Sydney, Sydney, Australia
SydPath, Saint Vincent’s Hospital, Sydney, Australia
Search for other papers by Tao Yang in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
Search for other papers by Charles Eugenio McCafferty in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
Centre for Oncology Education and Research Translation (CONCERT), Liverpool, New South Wales, Australia
Search for other papers by Nicole J Caixeiro in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
South West Sydney Clinical School, UNSW Sydney, Sydney, Australia
Search for other papers by Paul DeSouza in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
Department of Head & Neck Surgery, Liverpool Hospital, Liverpool, New South Wales, Australia
Department of Clinical Medicine, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia
Search for other papers by Navin Niles in
Google Scholar
PubMed
serum thyroglobulin (Tg) during TSH suppression (Tg <0.2 ng/mL) or following stimulation (Tg <1 ng/mL) with negative thyroglobulin antibodies. The patients that did not experience tumour persistence were censored at the last follow-up contact
Search for other papers by Xi Cao in
Google Scholar
PubMed
Search for other papers by Ming Lu in
Google Scholar
PubMed
Search for other papers by Rong-Rong Xie in
Google Scholar
PubMed
Search for other papers by Li-Ni Song in
Google Scholar
PubMed
Search for other papers by Wei-Li Yang in
Google Scholar
PubMed
Search for other papers by Zhong Xin in
Google Scholar
PubMed
Search for other papers by Guang-Ran Yang in
Google Scholar
PubMed
Search for other papers by Jin-Kui Yang in
Google Scholar
PubMed
population ( 6 ). Subclinical hypothyroidism (SCH), which is characterized by elevated thyroid-stimulating hormone (TSH), has attracted increasing attention, as it interacts with many metabolic diseases ( 7 , 8 ). Thyroid hormones, including TSH, have been
Search for other papers by Guoquan Zhu in
Google Scholar
PubMed
Search for other papers by Yuying Deng in
Google Scholar
PubMed
Search for other papers by Liqin Pan in
Google Scholar
PubMed
Search for other papers by Wei Ouyang in
Google Scholar
PubMed
Search for other papers by Huijuan Feng in
Google Scholar
PubMed
Search for other papers by Juqing Wu in
Google Scholar
PubMed
Search for other papers by Pan Chen in
Google Scholar
PubMed
Search for other papers by Jing Wang in
Google Scholar
PubMed
Search for other papers by Yanying Chen in
Google Scholar
PubMed
Search for other papers by Jiaxin Luo in
Google Scholar
PubMed
carcinoma were selected in this retrospective study. All patients had undergone total or near-total thyroidectomy, RAI therapy and suppressive therapy with thyroid-stimulating hormone (TSH) at the Zhujiang Hospital of Southern Medical University (Guangzhou
Search for other papers by Marek Niedziela in
Google Scholar
PubMed
common cause being their excessive tissue concentration. Graves’ disease (GD) is a form of autoimmune hyperthyroidism associated with the presence of autoantibodies stimulating the thyroid-stimulating hormone (TSH) receptor (TRAb). Epidemiology GD
Search for other papers by Kusum Lata in
Google Scholar
PubMed
Search for other papers by Pinaki Dutta in
Google Scholar
PubMed
Search for other papers by Subbiah Sridhar in
Google Scholar
PubMed
Search for other papers by Minakshi Rohilla in
Google Scholar
PubMed
Search for other papers by Anand Srinivasan in
Google Scholar
PubMed
Search for other papers by G R V Prashad in
Google Scholar
PubMed
Search for other papers by Viral N Shah in
Google Scholar
PubMed
Search for other papers by Anil Bhansali in
Google Scholar
PubMed
expected, the mean TSH in the TPOAb + group was higher (3.1±1.9) compared with that of the TPOAb − group (2.0±1.0). The early evaluation of human thyrocyte TSH receptor stimulating immunoglobulin bioassays with the sera of Graves' disease, Hashimoto
Search for other papers by Zhengrong Jiang in
Google Scholar
PubMed
Search for other papers by Linghong Huang in
Google Scholar
PubMed
Search for other papers by Lijun Chen in
Google Scholar
PubMed
Search for other papers by Jingxiong Zhou in
Google Scholar
PubMed
Search for other papers by Bo Liang in
Google Scholar
PubMed
Search for other papers by Xuefeng Bai in
Google Scholar
PubMed
Search for other papers by Lizhen Wu in
Google Scholar
PubMed
Search for other papers by Huibin Huang in
Google Scholar
PubMed
included the following ( 13 ): diffuse goitre, with symptoms of increased sweating, heat intolerance, elevated heart rate, elevated serum thyrotropin receptor antibody (TRAb), and low serum thyroid-stimulating hormone (TSH). The newly diagnosed GD patients
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
Search for other papers by Marra Jai Aghajani in
Google Scholar
PubMed
Saint Vincent’s Clinical School, UNSW Sydney, Sydney, Australia
SydPath, Saint Vincent’s Hospital, Sydney, Australia
Search for other papers by Tao Yang in
Google Scholar
PubMed
Gene & Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, New South Wales, Australia
Faculty of Medicine & Health, The University of Sydney, Camperdown, New South Wales, Australia
Search for other papers by Ulf Schmitz in
Google Scholar
PubMed
Search for other papers by Alexander James in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
Search for other papers by Charles Eugenio McCafferty in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
School of Medicine, University of Wollongong, New South Wales, Australia
Search for other papers by Paul de Souza in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
Department of Head & Neck Surgery, Liverpool Hospital, Liverpool, New South Wales, Australia
Department of Clinical Medicine, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia
Search for other papers by Navin Niles in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
South West Sydney Clinical School, UNSW Sydney, Sydney, Australia
Search for other papers by Tara L Roberts in
Google Scholar
PubMed
Association (ATA) Management Guidelines ( 25 ). An excellent response (absence of persistent tumour) following initial therapy was defined as negative imaging and either a low serum thyroglobulin (Tg) during thyroid stimulating hormone (TSH) suppression (Tg
Search for other papers by Bliss Anderson in
Google Scholar
PubMed
Search for other papers by Daniel L Morganstein in
Google Scholar
PubMed
). Prior use of a tyrosine kinase inhibitor also increases the risk of thyroid dysfunction ( 46 ). Raised levels of cytokines including IL-1β and IL-2 pre-treatment, as well as an early rise in thyroglobulin have been reported to predict thyroiditis ( 47
Search for other papers by Lauren E Henke in
Google Scholar
PubMed
Search for other papers by John D Pfeifer in
Google Scholar
PubMed
Search for other papers by Thomas J Baranski in
Google Scholar
PubMed
Search for other papers by Todd DeWees in
Google Scholar
PubMed
Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, Missouri, USA
Search for other papers by Perry W Grigsby in
Google Scholar
PubMed
consisted of physical examination and laboratory studies, including thyroid-stimulating hormone (TSH), triiodothyronine and free thyroxine for all patients, with the addition of thyroglobulin levels in the latter years of the study. Table 1 Patient
Search for other papers by Yun Cai in
Google Scholar
PubMed
Search for other papers by Jieni Yan in
Google Scholar
PubMed
Search for other papers by Yong Gu in
Google Scholar
PubMed
Search for other papers by Heng Chen in
Google Scholar
PubMed
Search for other papers by Yang Chen in
Google Scholar
PubMed
Search for other papers by Xinyu Xu in
Google Scholar
PubMed
Search for other papers by Mei Zhang in
Google Scholar
PubMed
Search for other papers by Liping Yu in
Google Scholar
PubMed
Search for other papers by Xuqin Zheng in
Google Scholar
PubMed
Search for other papers by Tao Yang in
Google Scholar
PubMed
of the presence of circulating autoantibodies such as thyrotropin receptor autoantibodies (TRAb), thyroid peroxidase autoantibodies (TPOAb) and thyroglobulin autoantibodies (TGAb). TRAb occurs predominantly in GD and plays a key role in Graves